130 related articles for article (PubMed ID: 35985635)
1. Catching BETs by viruses.
Zandian M; Chen IP; Byrareddy SN; Fujimori DG; Ott M; Kutateladze TG
Biochim Biophys Acta Gene Regul Mech; 2022 Oct; 1865(7):194859. PubMed ID: 35985635
[TBL] [Abstract][Full Text] [Related]
2. The Bromodomain and Extra-Terminal Domain (BET) Family: Functional Anatomy of BET Paralogous Proteins.
Taniguchi Y
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27827996
[TBL] [Abstract][Full Text] [Related]
3. RNAs interact with BRD4 to promote enhanced chromatin engagement and transcription activation.
Rahnamoun H; Lee J; Sun Z; Lu H; Ramsey KM; Komives EA; Lauberth SM
Nat Struct Mol Biol; 2018 Aug; 25(8):687-697. PubMed ID: 30076409
[TBL] [Abstract][Full Text] [Related]
4. Relevance of BET Family Proteins in SARS-CoV-2 Infection.
Lara-Ureña N; García-Domínguez M
Biomolecules; 2021 Jul; 11(8):. PubMed ID: 34439792
[TBL] [Abstract][Full Text] [Related]
5. Viral Hijacking of BET Proteins.
Chen IP; Ott M
Viruses; 2022 Oct; 14(10):. PubMed ID: 36298829
[TBL] [Abstract][Full Text] [Related]
6. Structure of the Brd4 ET domain bound to a C-terminal motif from γ-retroviral integrases reveals a conserved mechanism of interaction.
Crowe BL; Larue RC; Yuan C; Hess S; Kvaratskhelia M; Foster MP
Proc Natl Acad Sci U S A; 2016 Feb; 113(8):2086-91. PubMed ID: 26858406
[TBL] [Abstract][Full Text] [Related]
7. Metabolically Derived Lysine Acylations and Neighboring Modifications Tune the Binding of the BET Bromodomains to Histone H4.
Olp MD; Zhu N; Smith BC
Biochemistry; 2017 Oct; 56(41):5485-5495. PubMed ID: 28945351
[TBL] [Abstract][Full Text] [Related]
8. Affinity map of bromodomain protein 4 (BRD4) interactions with the histone H4 tail and the small molecule inhibitor JQ1.
Jung M; Philpott M; Müller S; Schulze J; Badock V; Eberspächer U; Moosmayer D; Bader B; Schmees N; Fernández-Montalván A; Haendler B
J Biol Chem; 2014 Mar; 289(13):9304-19. PubMed ID: 24497639
[TBL] [Abstract][Full Text] [Related]
9. WHAT do viruses BET on?
Weidner-Glunde M; Ottinger M; Schulz TF
Front Biosci (Landmark Ed); 2010 Jan; 15(2):537-49. PubMed ID: 20036832
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 envelope protein attain K
Agrahari AK; Srivastava M; Singh M; Asthana S
J Biomol Struct Dyn; 2023; 41(24):15305-15319. PubMed ID: 36907648
[TBL] [Abstract][Full Text] [Related]
11. The BRD3 ET domain recognizes a short peptide motif through a mechanism that is conserved across chromatin remodelers and transcriptional regulators.
Wai DCC; Szyszka TN; Campbell AE; Kwong C; Wilkinson-White LE; Silva APG; Low JKK; Kwan AH; Gamsjaeger R; Chalmers JD; Patrick WM; Lu B; Vakoc CR; Blobel GA; Mackay JP
J Biol Chem; 2018 May; 293(19):7160-7175. PubMed ID: 29567837
[TBL] [Abstract][Full Text] [Related]
12. Binding of the SARS-CoV-2 envelope E protein to human BRD4 is essential for infection.
Vann KR; Acharya A; Jang SM; Lachance C; Zandian M; Holt TA; Smith AL; Pandey K; Durden DL; El-Gamal D; Côté J; Byrareddy SN; Kutateladze TG
Structure; 2022 Sep; 30(9):1224-1232.e5. PubMed ID: 35716662
[TBL] [Abstract][Full Text] [Related]
13. Bromodomain and extraterminal inhibitors block the Epstein-Barr virus lytic cycle at two distinct steps.
Keck KM; Moquin SA; He A; Fernandez SG; Somberg JJ; Liu SM; Martinez DM; Miranda JL
J Biol Chem; 2017 Aug; 292(32):13284-13295. PubMed ID: 28588024
[TBL] [Abstract][Full Text] [Related]
14. Characterization of multiple interactions between the envelope E protein of SARS-CoV-2 and human BRD4.
Zandian M; Jang SM; Lachance C; Acharya A; Byrareddy SN; Côté J; Kutateladze TG
STAR Protoc; 2022 Dec; 3(4):101853. PubMed ID: 36595918
[TBL] [Abstract][Full Text] [Related]
15. Bromodomain inhibitors and therapeutic applications.
Gajjela BK; Zhou MM
Curr Opin Chem Biol; 2023 Aug; 75():102323. PubMed ID: 37207401
[TBL] [Abstract][Full Text] [Related]
16. Distinct layers of BRD4-PTEFb reveal bromodomain-independent function in transcriptional regulation.
Zheng B; Gold S; Iwanaszko M; Howard BC; Wang L; Shilatifard A
Mol Cell; 2023 Aug; 83(16):2896-2910.e4. PubMed ID: 37442129
[TBL] [Abstract][Full Text] [Related]
17. BET Bromodomain as a Target of Epigenetic Therapy.
Noguchi-Yachide T
Chem Pharm Bull (Tokyo); 2016; 64(6):540-7. PubMed ID: 27250788
[TBL] [Abstract][Full Text] [Related]
18. Viral E protein neutralizes BET protein-mediated post-entry antagonism of SARS-CoV-2.
Chen IP; Longbotham JE; McMahon S; Suryawanshi RK; Khalid MM; Taha TY; Tabata T; Hayashi JM; Soveg FW; Carlson-Stevermer J; Gupta M; Zhang MY; Lam VL; Li Y; Yu Z; Titus EW; Diallo A; Oki J; Holden K; Krogan N; Fujimori DG; Ott M
Cell Rep; 2022 Jul; 40(3):111088. PubMed ID: 35839775
[TBL] [Abstract][Full Text] [Related]
19. Alternative Mechanisms for DNA Engagement by BET Bromodomain-Containing Proteins.
Kalra P; Zahid H; Ayoub A; Dou Y; Pomerantz WCK
Biochemistry; 2022 Jul; 61(13):1260-1272. PubMed ID: 35748495
[TBL] [Abstract][Full Text] [Related]
20. BRD4 in physiology and pathology: ''BET'' on its partners.
Liang Y; Tian J; Wu T
Bioessays; 2021 Dec; 43(12):e2100180. PubMed ID: 34697817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
